Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;114(6):1445-1455.
doi: 10.1111/apa.17591. Epub 2025 Jan 21.

Assessment of Fasting Metabolism With Microdialysis Indicates Earlier Lipolysis in Children With VLCADD Than MCADD

Affiliations

Assessment of Fasting Metabolism With Microdialysis Indicates Earlier Lipolysis in Children With VLCADD Than MCADD

David Olsson et al. Acta Paediatr. 2025 Jun.

Abstract

Aim: To investigate fasting metabolism in children with very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and medium-chain acyl-CoA dehydrogenase deficiency (MCADD) using microdialysis technique.

Methods: Twelve patients (7 with VLCADD, 5 with MCADD, mean age 4.9 years, 10/12 diagnosed via newborn screening) were recruited for investigation in connection to clinical fasting examinations at the Karolinska University Hospital (between 2015 and 2024). Patients were subjected to a 9-h night fast after a standard late evening meal. Analysis of glucose, glycerol, lactate, and pyruvate was conducted by continuous microdialysis. Fasting hormones and acylcarnitines were analysed in blood samples at 1-h intervals in patients with VLCADD.

Results: Children with VLCADD showed signs of lipolysis after a median fasting time of 4.5 h, whereas patients with MCADD showed no significant increase in lipolysis during the fast. A shorter time to initiation of lipolysis tended to correlate with a lower residual enzyme activity in patients with VLCADD. All patients maintained euglycemia during fasting.

Conclusion: Children with VLCADD had a shorter time to initiation of lipolysis during fasting than children with MCADD. Clinical evaluation of fasting metabolism in beta-oxidation disorders should include assessment of lipolysis as an early and important determinant.

Keywords: Beta‐oxidation disorders; MCADD; VLCADD; fasting intolerance; microdialysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Study protocol.
FIGURE 2
FIGURE 2
Microdialysis monitoring of glycerol.
FIGURE 3
FIGURE 3
Acylcarnitines, fasting hormones and plasma glucose in patients with VLCADD.

Similar articles

References

    1. Houten S. M., Violante S., Ventura F. V., and Wanders R. J. A., “The Biochemistry and Physiology of Mitochondrial Fatty Acid β‐Oxidation and Its Genetic Disorders,” Annual Review of Physiology 78, no. 1 (2016): 23–44, 10.1146/annurev-physiol-021115-105045. - DOI - PubMed
    1. Miller M. J., Cusmano‐Ozog K., Oglesbee D., Young S., and Committee A. L. Q. A., “Laboratory Analysis of Acylcarnitines, 2020 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG),” Genetics in Medicine 23, no. 2 (2021): 249–258, 10.1038/s41436-020-00990-1. - DOI - PubMed
    1. Baruteau J., Sachs P., Broué P., et al., “Clinical and Biological Features at Diagnosis in Mitochondrial Fatty Acid Beta‐Oxidation Defects: A French Pediatric Study of 187 Patients,” Journal of Inherited Metabolic Disease 36, no. 5 (2013): 795–803, 10.1007/s10545-012-9542-6. - DOI - PubMed
    1. Knottnerus S. J. G., Bleeker J. C., Wüst R. C. I., et al., “Disorders of Mitochondrial Long‐Chain Fatty Acid Oxidation and the Carnitine Shuttle,” Reviews in Endocrine & Metabolic Disorders 19, no. 1 (2018): 93–106, 10.1007/s11154-018-9448-1. - DOI - PMC - PubMed
    1. Vianey‐Saban C., Divry P., Brivet M., et al., “Mitochondrial Very‐Long‐Chain Acyl‐Coenzyme A Dehydrogenase Deficiency: Clinical Characteristics and Diagnostic Considerations in 30 Patients,” Clinica Chimica Acta 269, no. 1 (1998): 43–62, 10.1016/s0009-8981(97)00185-x. - DOI - PubMed

Substances

Supplementary concepts